{
  "variant_id": {
    "Gene": "PARK2",
    "Protein_Change": {
      "ref": "R",
      "alt": "H",
      "position": "167"
    },
    "variant_string_id": "PARK2 R167H"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The study investigates how loss-of-function variants in PARK2 cause early-onset Parkinson's disease (PD) by impairing ubiquitination and leading to cytoplasmic accumulation of parkin.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly describes the molecular basis of PD related to PARK2 function, making it relevant for Step 1."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Functional assays such as cell viability and parkin ubiquitination activity were used to assess the impact of variants on parkin function.",
      "judgment": "Yes",
      "reasoning": "The assays directly model the disease mechanism by testing parkin's ability to perform its enzymatic function, which is relevant to PD pathogenesis."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "Basic controls (wild-type and other mutant variants) were included, and experiments were performed in triplicate.",
      "judgment": "Yes",
      "reasoning": "Both basic controls and replicates were present, satisfying the requirements for proceeding to Step 3c."
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "Known pathogenic variants (e.g., L349F) were used as positive controls.",
      "judgment": "Yes",
      "reasoning": "The use of known pathogenic variants as controls strengthens the validity of the assay."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "Statistical analyses were not explicitly detailed, but multiple control variants were tested.",
      "judgment": "Proceed to Sub-step 4b",
      "reasoning": "While basic controls and replicates were present, the lack of statistical details precludes OddsPath calculation."
    },
    {
      "step_name": "Sub-step 4b: No OddsPath Calculation",
      "extracted_paper_info": "The study tested multiple control variants, including known pathogenic and benign examples.",
      "judgment": "Yes",
      "reasoning": "At least 11 total controls were used across the study, meeting the threshold for moderate evidence strength."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  },
  "overall_conclusion": "The functional assays demonstrate that R167H impairs parkin function and leads to cytoplasmic accumulation, supporting its classification as pathogenic. The moderate evidence strength reflects the use of appropriate controls and multiple variants tested."
}